Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial

INTRODUCTION: The poor prognosis of ovarian carcinoma (OvC) is due to the advanced stage at diagnosis, a high risk of relapse after first-line therapies, and the lack of efficient treatments in the recurrence setting. Circulating tumor DNA (ctDNA) analysis is a promising tool to assess treatment-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatier, Renaud, Garnier, Séverine, Guille, Arnaud, Carbuccia, Nadine, Pakradouni, Jihane, Adelaide, José, Provansal, Magali, Cappiello, Maria, Rousseau, Frédérique, Chaffanet, Max, Birnbaum, Daniel, Mamessier, Emilie, Gonçalves, Anthony, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373051/
https://www.ncbi.nlm.nih.gov/pubmed/35965534
http://dx.doi.org/10.3389/fonc.2022.946257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373051/
https://www.ncbi.nlm.nih.gov/pubmed/35965534
http://dx.doi.org/10.3389/fonc.2022.946257

Ejemplares similares